E8 Short oral presentations, Part 1 (Industry & Science)
Monday 29 August 2016
14:30-17:30
Hilton Buenos Aires : Pacifico B, 3 hours
Organised by the FIP sections and special interest groups
Chairs
Gabrielle Wiederkehr (Access Regulatory Consulting, Switzerland) and Igor Linhares de Castro (BiocadBrazil, Brazil)
Programme
14:30
1) Vancomycin Plasma measurements change prescription in real time against Staphylococcus SPP MIC 2mg/l in critically ill paediatrics
Silvia Regina Cavani Jorge (Santos University of Sao Paulo, Brazil)
14:45
2) Urinary excretion of ciprofloxacin after administration of extended release tablet in healthy volunteers. Hydrophilic carbomer-ciprofloxacin matrix versus bilayer tablets
María Eugenia Olivera (Facultad de Ciencias Químicas-Universidad Nacional de Córdoba, Argentina)
15:00
3) Induction of UDP-glucuronosyltransferase 1A1 during the perinatal period can reduce blood thyroxine levels, causing neurodevelopmental toxicity
Ryoichi Fujiwara (Kitasato University, Japan)
15:15
4) Untargeted metabolomic studies in cardiovascular diseases on the example of early vascular ageing (EVA) syndrome
Michal Markuszewski (Medical University of Gdansk, Poland)
15:30
5) Comparison of minoxidil penetration when applied on damp or dry scalp
Tamara Ângelo (Universidade de Brasilia, Brazil)
15:45 – 16:00 Coffee/tea break
16:00
6) Hypnosis of Propofol is altered by coronary artery bypass grafting in surgical patients as a consequence of reduction on drug plasma protein binding
Silvia Regina Cavani Jorge (Santos University of Sao Paulo, Brazil)
16:15
7) ƴ-Glutamylcysteine exhibits anti-inflammatory effects via down-regulation of TNF-α and the JNK pathway in acute pancreatitis
Pablo Marti Andres (Universidad de Valencia, Spain)
16:30
8) Results of a pharmacist-led pharmacogenomics service for community-based frail elderly
Emily Schwartz (Tabula Rasa HealthCare, USA)
16:45
9) Radiopharmaceutical waste disposal in Turkey and the world
A. Yekta Ozer (Hacettepe University, Turkey)
17:00
10) Native-American contribution in Puerto Ricans is associated with a lower warfarin dose requirement
Karla Claudio (University of Puerto Rico, Puerto Rico)
17:15
11) Driving medicine quality assurance through effective and appropriate utilization of surveillance and screening technologies
Lukas Roth (U.S. Pharmacopeial Convention, USA)